External motivation | Introjected motivation | Identified motivation | |||||||
---|---|---|---|---|---|---|---|---|---|
β | 95% CI | p value | β | 95% CI | p value | β | 95% CI | p value | |
Intercept | 12.45 | 2.96; 21.94 | 0.011 | 5.71 | −6.01; 17.41 | 0.341 | 7.41 | −3.85; 18.67 | 0.197 |
Condition | 0.37 | −2.49; 3.23 | 0.799 | − 2.39 | −6.22; 1.44 | 0.222 | −0.91 | −4.42; 2.61 | 0.613 |
Gender | 1.61 | −1.82; 5.04 | 0.358 | 0.57 | −4.09; 5.24 | 0.811 | −3.76 | −8.04; 0.52 | 0.085 |
Substance use | 1.09 | −1.88; 4.06 | 0.472 | 0.77 | −3.26; 4.79 | 0.708 | −0.28 | −3.97; 3.42 | 0.884 |
Medication adherence baselinea | −0.03 | −0.11; 0.06 | 0.548 | 0.04 | −0.07; 0.16 | 0.506 | 0.09 | −0.02; 0.19 | 0.103 |
Motivation baselineb | 0.43 | 0.25; 0.61 | < 0.001 | 0.61 | 0.41; 0.81 | < 0.001 | 0.56 | 0.39; 0.72 | < 0.001 |
Medication side-effects | −0.12 | −0.54; 0.29 | 0.571 | −0.11 | −0.67; 0.46 | 0.714 | 0.34 | −0.16; 0.84 | 0.181 |
Illness insight | −0.29 | −1.13; 0.54 | 0.486 | −1.33 | −2.47; − 0.19 | 0.023 | −1.65 | −2.72; − 0.59 | 0.002 |
Medication adherence 12 months | −0.03 | − 0.14; 0.07 | 0.542 | − 0.02 | −0.16; 0.12 | 0.796 | 0.02 | −0.11; 0.15 | 0.711 |